Fierce Pharma
NOVEMBER 20, 2024
As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety findings” linked to the British drugmaker’s bleeding reversal agent.
MedCity News
NOVEMBER 20, 2024
Ensuring that family caregivers, and hospice providers all get the support that they need is more than just about ensuring that a patient receives end-of-life care with the dignity and support they deserve. The post Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 20, 2024
Johnson & Johnson and Merck are laying off workers in Chi | Johnson & Johnson and Merck are laying off workers in China, according to a story from Bloomberg which cites reports from Chinese news outlets.
MedCity News
NOVEMBER 20, 2024
World Class Health’s $8 million in seed funding was led by AlleyCorp. The company serves self-funded employers and offers access to a global centers of excellence network. The post World Class Health Snags $8M To Expand Global Centers of Excellence Network appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
NOVEMBER 20, 2024
With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the drawing board for Canadian private equity outfit Brookfield. | Grifols’ board of directors on Tuesday rebuffed private equity firm Brookfield’s potential 6.45 billion euro buyout offer, recommending management reject the deal that it argues “significantly undervalues the company’s fundamental prospects and its long-term potential.
MedCity News
NOVEMBER 20, 2024
Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits. The post MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 20, 2024
Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry. The post Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D appeared first on MedCity News.
Fierce Pharma
NOVEMBER 20, 2024
It was only last October that UCB’s up-and-coming immunology powerhouse Bimzelx first crossed the FDA finish line in psoriasis after an initial delay. | The latest nod positions Bimzelx to go head-to-head with Novartis' Cosentyx in the hidradenitis suppurativa market.
Pharmaceutical Technology
NOVEMBER 20, 2024
The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for the third time.
Fierce Pharma
NOVEMBER 20, 2024
Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are already eying the blockbuster as a potential target. | The spinal muscular atrophy drug is a growth driver for the Swiss pharma giant, prompting the company to prioritize its defense against potential generics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
NOVEMBER 20, 2024
We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics. The post Polypharmacy is a Health Killer: Personalized Medication Management is the Answer appeared first on MedCity News.
Fierce Pharma
NOVEMBER 20, 2024
On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics is adding yet another project to its contract manufacturing Rolodex. | Samsung Biologics said it inked a series of production pacts with an unnamed European pharma in a tie-up worth a total of $668 million. Samsung’s latest undertaking, which will see the CDMO provide manufacturing services to its client through 2031, brings the company’s cumulative new contract value this
MedCity News
NOVEMBER 20, 2024
A Utah-based startup named Orion Innovations released two studies this month demonstrating its product’s efficacy. The device attaches to hospital IV lines and uses a light to assist nurses with the identification and tracing of medication infusion lines, with the goal of reducing errors. The post Orion Innovations’ Light-Up Infusion Device Helps Both Patients and Nurses, Research Shows appeared first on MedCity News.
pharmaphorum
NOVEMBER 20, 2024
MSD's subcutaneous formulation of top-selling cancer drug Keytruda was non-inferior to the current intravenous version in a head-to-head trial
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Integrity Solutions
NOVEMBER 20, 2024
The road to success in sales is filled with challenges, highs and lows. Many variables come into play. As we note in our book, Listen to Sell , “It can be easy to feel that given the right factors—the market, the product, the tools, the data, the competition, a natural sales ability—selling would be easier, and success would be inevitable.” But this is a passive and, ultimately, self-defeating way to view and approach the profession of sales.
pharmaphorum
NOVEMBER 20, 2024
Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU
PharmaTimes
NOVEMBER 20, 2024
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles
pharmaphorum
NOVEMBER 20, 2024
Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available to breast cancer patients on the NHS have been abandoned
Pharmaceutical Commerce
NOVEMBER 20, 2024
Pharmaceutical companies are transforming how they connect with healthcare professionals (HCPs) by leveraging AI using more complex data and integration strategies. Close-Up CRM incorporates these advancements by leveraging AI to empower teams with precision-targeted engagements, and delivery of the right message to the right HCP at the right time. The intuitive user-friendly platform provides the field intelligence teams with needed information that's always ready.
pharmaphorum
NOVEMBER 20, 2024
Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease
Pharmaceutical Commerce
NOVEMBER 20, 2024
As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
Pharma Marketing Network
NOVEMBER 20, 2024
Table of Contents Sr# Headings 1 Introduction 2 What Is Display Advertising? 3 Why Display Advertising Matters in Pharma 4 Key Benefits of Display Advertising 5 Targeting: Reaching the Right Audience 6 Personalization in Display Ads 7 Case Study: Successful Pharma Display Campaigns 8 Choosing the Right Platforms 9 Metrics to Track for ROI Success 10 Regulatory Challenges and Solutions 11 The Role of Branded Drugs in Display Ads 12 Creative Best Practices for Display Ads 13 Aligning Display Ads w
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Contrarian Sales Techniques
NOVEMBER 20, 2024
In underserved regions of Malaysia, where healthcare resources are limited, medical reps play a pivotal role. It’s not just about selling products – it’s about shaping how doctors prescribe, ensuring patients have access to affordable, effective treatments. For many reps, this isn’t just a job – it’s a chance to make a real difference. Why Medical Reps Are Vital in These Regions Doctors in underserved areas often face challenges like limited access to the latest medical updates or a narrow range
Pharma Marketing Network
NOVEMBER 20, 2024
Table of Contents Sr# Headings 1 Introduction 2 What Is an Ad Exchange? 3 Why Pharma Marketing Needs Ad Exchanges 4 How Ad Exchanges Work 5 Benefits of Using Ad Exchanges 6 Programmatic Advertising and Ad Exchanges 7 Key Platforms for Pharma Marketers 8 Targeting Specific Audiences Through Ad Exchanges 9 Measuring Success and ROI 10 Compliance Challenges and Solutions 11 Ad Exchange Success Stories in Pharma 12 Aligning Ad Exchange with Omnichannel Strategies 13 Trends in Pharma Advertising via
Contrarian Sales Techniques
NOVEMBER 20, 2024
I know that most of you have never worked in pharma sales in Malaysia. I’d like you all to know that rural clinics often lean towards established brands. It’s not just about the product – it’s about familiarity, trust, and the assurance that these brands deliver consistent quality. Let’s explore why this preference matters and how it shapes the rural market.
Pharmaceutical Commerce
NOVEMBER 20, 2024
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.
Contrarian Sales Techniques
NOVEMBER 20, 2024
In the fast-paced world of pharma sales in Malaysia, opportunities can come when you least expect them. One such golden moment? When your competitors face stock shortages. These ‘lucky’ market breaks don’t happen often, but when they do, they can open doors for your products to gain a foothold. What Are Market Breaks? Market breaks occur when a competitor’s product goes out of stock, creating a gap in the market.
European Pharmaceutical Review
NOVEMBER 20, 2024
Researchers in Israel have developed a way to obtain high-resolution imagery using megapixel fluorescence microscopy without needing specialist equipment. The technique enables clear images of dense and challenging targets to be captured. It can correct computational scattering, which is one of the main limitations in fluorescence imaging, according to the paper that discusses the study findings.
Contrarian Sales Techniques
NOVEMBER 20, 2024
In the age of Zoom calls and WhatsApp messages, you might think digital communication is king. But when it comes to pharmacists in Malaysia, old-school, in-person interactions still reign supreme. Why? Because nothing beats the trust and connection that come from a face-to-face conversation. Why Pharmacists Value In-Person Detailing Pharmacists in Malaysia, especially those in independent pharmacies or smaller chains, rely heavily on direct communication to understand the nuances of new products
Pharmaceutical Technology
NOVEMBER 20, 2024
Discover leading sales enablement and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to market forecasts and industry insights.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
321 
Let's personalize your content